Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Jan 07, 2025 6:23pm
139 Views
Post# 36393314

New Evidence Shows DEA Opposes Marijuana Rescheduling

New Evidence Shows DEA Opposes Marijuana Rescheduling

the attorneys said the timing of the DEA’s declaration filing is further evidence that DEA opposes the policy change, noting that the agency was statutorily required to submit any relevant data on the proposed rule before HHS carried out its scientific review and the rulemaking process was formally initiated.

“By waiting until practically the eve of the hearing to submit its data, DEA has thwarted HHS’s review, sidestepped the notice-and-comment process, and deprived pro-rescheduling [designated participants, or DPs] of the fair and transparent hearing that the Administrative Procedure Act (APA) and due process require,” it says. “In so doing, DEA has violated the CSA, the APA, and its own regulations.”

The motion then alleges that there’s “additional damning evidence of ex parte and undisclosed communications has emerged,” with DEA failing to disclose nearly 100 requests to participate in the upcoming hearings, as well as “communication and coordination with at least one anti-rescheduling DP, the Tennessee Bureau of Investigation.”

https://www.marijuanamoment.net/new-evidence-shows-dea-opposes-marijuana-rescheduling-and-should-be-removed-from-hearings-cannabis-groups-say/

<< Previous
Bullboard Posts
Next >>